ArticleJournal of gastrointestinal oncology2021
Peritoneal progression after pancreaticoduodenectomy is a devastating surgical treatment failure: HIPEC gemcitabine is an option.
Paul H Sugarbaker et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.